Ethiopia's food and drug regulator has issued a final warning to companies and individuals advertising medical devices without prior approval, saying it will pursue legal action against those that continue to promote products in breach of the country's medicines law.
The Ethiopian Food and Drug Authority (EFDA) said it had identified a growing number of medical device advertisements on social media platforms that had not undergone the regulator's mandatory review and approval process. It also found that some products being promoted through social media fall into categories that are prohibited from being advertised through such channels under existing regulations.
The regulator ordered all unauthorised medical device advertisements to be removed immediately from mainstream media and digital platforms, including TikTok, YouTube and Facebook. It said any future advertising or promotional activity must receive official EFDA approval before publication and comply with all applicable regulatory requirements.
The warning is based on the Food and Medicine Administration Proclamation No. 1112/2019, which assigns EFDA responsibility for overseeing the safety, quality and performance of medical devices, including the regulation of their advertising and promotion.
Under the proclamation, promotional materials for medical devices must be evaluated and authorised by the regulator before use. The law also requires that direct promotion to healthcare professionals be conducted only by authorised medical device promoters, prohibits financial or in-kind incentives outside limits established by regulation, and bans the promotion of medicines and medical devices within health institutions without official permission.
EFDA said it has been granting promotional approvals for eligible medical devices after reviewing submitted materials in line with the proclamation and related directives. However, it said recent monitoring showed that a number of advertisers had bypassed the approval process.
The authority said non-compliance with the directive would result in legal measures against individuals or organisations that continue to advertise or promote medical devices without regulatory authorisation.
The latest warning forms part of EFDA's enforcement of Ethiopia's pharmaceutical and medical device regulatory framework, which requires promotional claims to be assessed before products are marketed to healthcare professionals or the public.
